Novel Salvage Regimens Lead to Better Response and Survival in Relapsed Refractory Classic Hodgkin Lymphoma after Autologous Stem Cell Transplant
Year: 2021
Type: conference-abstract
Source: Blood
Authors: Sanjal H Desai, Michael A Spinner, Kevin A. David, Veronika Bachanova, Gaurav Goyal, Jacques Azzi, Kathleen Dorritie, Vaishalee P. Kenkre, Cheryl Chang, Sally Arai, Brendon Fusco, Nuttavut Sumransub, Haris Hactic, Uroosa Ibrahim, Elyse Harris, Matthew J. Maurer, KC Rappazzo, Victor M. Orellana-Noia, Catherine S. Diefenbach, Saba Raya, Grzegorz S. Nowakowski, Ranjana Advani, Ivana N. Micallef
Institutions: Mayo Clinic, Stanford Medicine, Stanford University, Rutgers, The State University of New Jersey, Rutgers Cancer Institute, University of Minnesota, University of Alabama at Birmingham, Icahn School of Medicine at Mount Sinai, UPMC Hillman Cancer Center, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, O'Neal Comprehensive Cancer Center, Mount Sinai Hospital, Johns Hopkins University, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center, Emory University, Winship Cancer Institute, NYU Langone Health, New York University, Washington University in St. Louis, Stanford Cancer Institute
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3211897764